The promotion of miR-145 by 20(S)-Rg3 directly targeted FSCN1 to reverse EMT in vitro and vivo. These results not only uncovered the novel anti-cancer mechanism of 20(S)-Rg3, but also revealed the regulatory pathway for miR-145 expression. The gene discussed is FSCN1; the disease is cancer.